[1] MOREAU R,JALAN R,GINES P,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology,2013,144(7):1426-1437.
|
[2] BAJAJ JS. Defining acute-on-chronic liver failure:Will east and west ever meet?[J]. Gastroenterology,2013,144(7):1337-1339.
|
[3] HERNAEZ R,SOLA E,MOREAU R,et al. Acute-on-chronic liver failure:An update[J]. Gut,2017,66(3):541-553.
|
[4] STRAVITZ RT. Acute-on-chronic liver failure—no longer an entity without definition[J]. Nat Rev Gastro Hepat,2014,11(10):580-581.
|
[5] ANGELI P,BERNARDI M,VILLANUEVA C,et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol,2018,69(2):406-460.
|
[6] TREBICKA J. Predisposing factors in acute-on-chronic liver failure[J]. Semin Liver Dis,2016,36(2):167-173.
|
[7] ROSSLE M. TIPS:25 years later[J]. J Hepatol,2013,59(5):1081-1093.
|
[8] BERRES M,ASMACHER S,LEHMANN J,et al. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt[J]. J Hepatol,2015,62(2):332-339.
|
[9] BERRES ML,LEHMANN J,JANSEN C,et al. Chemokine(C-X-C motif)ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt[J].Liver Int,2016,36(3):386-394.
|
[10] HERNANDEZ-GEA V,PROCOPET B,GIRLDEZ,et al.Preemptive-TIPS improves outcome in high-risk variceal bleeding:An observational study[J]. Hepatology,2019,69(1):282-293.
|
[11] PRAKASH R,MULLEN KD. Mechanisms,diagnosis and management of hepatic encephalopathy[J]. Nat Rev Gastroenterol Hepatol,2010,7(9):515-525.
|
[12] KUMAR A,DAS K,SHARMA P,et al. Hemodynamic studies in acute-on-chronic liver failure[J]. Digest Dis Sci,2009,54(4):869-878.
|
[13] GARG H,KUMAR A,GARG V,et al. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure[J]. J Gastroen Hepatol,2013,28(8):1361-1367.
|
[14] CHEN Y,GUO J,QIAN G,et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality[J].J Gastroen Hepatol,2015,30(9):1429-1437.
|
[15] BAFFY G. Potential mechanisms linking gut microbiota and portal hypertension[J]. Liver Int,2019,39(4):598-609.
|
[16] FERNANDEZ J,ACEVEDO J,WIEST R,et al. Bacterial and fungal infections in acute-on-chronic liver failure:Prevalence,characteristics and impact on prognosis[J]. Gut,2018,67(10):1870-1880.
|
[17] TREBICKA J,KRAG A,GANSWEID S,et al. Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension[J]. PLo S One,2013,8(12):e83341.
|
[18] DURAND F,NADIM MK. Management of acute-on-chronic liver failure[J]. Semin Liver Dis,2016,36(2):141-152.
|
[19] MAIWALL R,JAMWAL KD,BHARDWAJ A,et al. SX-Ella stent danis effectively controls refractory variceal bleed in patients with acute-on-chronic liver failure[J]. Digest Dis Sci,2018,63(2):493-501.
|
[20] GUEVARA M,GINES P,BANDI JC,et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome:Effects on renal function and vasoactive systems[J]. Hepatology,1998,28(2):416-422.
|
[21] MOOKERJEE RP,PAVESI M,THOMSEN KL,et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure[J]. J Hepatol,2016,64(3):574-582.
|
[22] CARDENAS A,SOLA E,RODRIGUEZ E,et al. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure:An analysis of the CANONIC study[J]. Crit Care,2014,18(6):700.
|
[23] PREMKUMAR M,SAXENA P,RANGEGOWDA D,et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure:An observational cohort study[J]. Liver Int,2019,39(4):694-704.
|